Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WARFASA: Aspirin for Prevention of Recurrent VTE
NCT00222677Phase 3Unknown
- Sponsor
- University of Perugia
- Start
- May 2004
- Primary completion
- Jan 2012
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 3 trial of aspirin in venous thromboembolism (VTE), sponsored by University of Perugia. Status: unknown.
02
Drugs
aspirin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT00222677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00222677.